COPD

What is COPD?

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes breathing harder over time. It often includes emphysema, chronic bronchitis, or both. Cigarette smoking is the most common cause in the general population. Genetic Alpha-1 Antitrypsin Deficiency (AATD) is an important cause of COPD that is still underdiagnosed.

This page explains the established connection between AATD and COPD. It is education, not a diagnosis or treatment plan. Always work with your clinician.

How Alpha-1 relates to COPD (established)

Alpha-1 Antitrypsin (AAT) protects lung tissue from neutrophil elastase and related enzymes. When AAT is missing or dysfunctional because of SERPINA1 gene variants (for example PI*ZZ), the lungs can be damaged earlier and more severely. That damage often presents as emphysema or COPD, including in people who never smoked or who smoked relatively little.

Clues that COPD may be related to AATD include:

• Early onset emphysema or COPD
• COPD in a never smoker or light smoker
• Family history of AATD, early emphysema, or unexplained liver disease
• Unexplained liver disease alongside lung disease

Symptoms people often search for

Common COPD related symptoms include chronic cough, sputum, shortness of breath with activity, wheezing, and frequent respiratory infections. AATD related lung disease can look like ordinary COPD. That is why testing matters when the story does not fit smoking exposure alone.

See our symptoms overview and educational self-check.

Testing and diagnosis

When COPD or emphysema seems disproportionate to exposure history, clinicians often order a serum AAT level and follow up with phenotyping or genotyping. Read more in AATD diagnosis and testing and genetic testing for COPD.

Treatment education

COPD care includes inhalers, pulmonary rehab, vaccines, oxygen when indicated, and smoking cessation support. For severe AATD with emphysema, augmentation therapy (AAT replacement) may be discussed with a specialist. See medications and treatments for Prolastin, Zemaira, Glassia, and related education.

Related pages

• Emphysema and Alpha-1
• Hereditary emphysema context on symptoms
• Related conditions
• What is Alpha-1 Antitrypsin Deficiency
• Ways to give

Research hypotheses beyond classic lung disease

Mark Egly's patent also explores broader inflammatory and disease associations beyond classic AATD lung and liver disease. Those claims are labeled as research hypotheses on other disease pages and hubs. Classic AATD related COPD and emphysema remain established clinical knowledge.